Search Follow us



EdisonTV | Pharmaceuticals & healthcare | 25/09/2018

Bitesize briefing - Nuevolution

Nuevolution is a Copenhagen-based biopharmaceutical company with a patent-protected drug discovery platform (Chemetics) that enables the selection of drugs for an array of tough-to-drug disease targets. In this video, healthcare analyst Dr Daniel Wilkinson presents an overview of Nuevolution, covering its technology, financial position, partnerships and the wider competitive landscape. Additionally he details Edison’s approach to valuing the company.

Read the report

» Nuevolution overview & latest research